Now AvailableTandem Mobi

A system so small that it can be worn almost anywhere, giving you greater discretion.*

We know that diabetes management is a personal journey. That’s why we deliver cutting-edge insulin pumps and technology that adapt to your life, so you can choose what works best for you.

Insulin Pump

Choose between two different insulin pumps with Control-IQ+ technology.

CGM Sensor

Integrate with the Dexcom G7 CGM.^†

Infusion Sets

Select between different insertion angles and a variety of tubing lengths.

Software Tools

Use mobile^‡ and cloud-based applications^§ to clearly see therapy trends.

Automated Insulin Delivery

Control-IQ+ technology, a powerful algorithm on our insulin pumps, uses CGM values to predict glucose levels and automatically adjust insulin delivery every 5 minutes. It can also deliver an AutoBolus^{^} to help prevent hyperglycaemia.

Percentage of time real-world users spent in range between the hours of 4 am and 7 am while using Control-IQ+ technology.¹

Tested

Best-in-Class Outcomes with Control-IQ+

Within 24 hours, Control-IQ+ users saw immediate time-in-range improvements.²

Percentage that diabetes burden decreased, including better blood glucose control and improved quality of life, with Control-IQ+.³

Trusted: Control-IQ+ has 550,000+ users worldwide with more than 300 million patient days!⁴

My [HbA1c] has been amazing since I switched to Tandem. I used to wake up with lows, and that’s scary. But Tandem is my safety net. I don’t worry about overnight lows anymore. Izzy, diagnosed 2016

Note: Individual symptoms, situations, circumstances, and results may vary. Adhesive sleeve sold separately.

* Do not wear or place your pump more than 30.5 cm (12 inches) above your infusion site. Doing so may result in over delivery of insulin.
† CGM sold separately.
‡ Our mobile apps require a compatible smartphone model and operating system (sold separately).
§ Uploads to the Tandem Source platform do not take place in real time and should not be relied upon by healthcare providers or caregivers for remote patient monitoring. Standard carrier data rates may apply.
^ If glucose values are predicted to be above 10.0 mmol/L (180 mg/dL), Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 6.1 mmol/L (110 mg/dL) and delivers 60% of that value.

References

Note: The first two studies below were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 sensor.
1. Breton MD, Kovatchev BP. Diabetes Technol Ther. 2021;23(9):601-608.
2. Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
3. Graham R, et al. Diabetes Technol Ther. 2024;26(1):24-32.
4. As of April, 2026. Data on file, Tandem Diabetes Care.

Important Safety Information